Summary

A panel of 4 experts explored clinical guidelines regarding pacing, implantable cardioverter-defibrillators, and cardiac resynchronization therapy. Two speakers also debated clinical, financial, and ethical questions related to continued use of cardiac resynchronization therapy in the setting of clinical improvement, such as an improved left ventricular ejection fraction.

  • atrioventricular block
  • cardiac resynchronization therapy
  • generator replacement
  • implantable cardioverter defibrillators
  • left ventricular ejection fraction
  • pacemaker
View Full Text